Identiﬁcation of antibiotic-resistance genes of those patients who present to the ED, or enter post treatment facilities such as LTACs and SNFs with symptoms of infection, and who are in a high-risk group as noted above, is central to meeting core measures. Carefully collected specimens that are representative of the infectious process should be used to determine the presence of multidrug-resistant organisms.
Patients who are symptomatic with no particular focus of infections, such as fever of unknown origin, can be screened for an antibiotic resistance mechanism using a carefully collected rectal swab. Patients who are colonized with bacteria that carry a gene that codes for antibiotic resistance typically shed these organisms via the alimentary tract. Therefore, a careful sampling of the mucosal surface of the lower sigmoid colon is ideal to identify carriers of antibiotic-resistant bacteria.
Benefits of Our Unique Results Report
- RESULTS AVAILABLE NEXT DAY
- TESTS PERFORMED UTILIZING QUANTITATIVE REAL-TIME PCR (qPCR)
- GREATER THAN 99% SENSITIVITY & SPECIFICITY
- RESULTS UNAFFECTED BY CURRENT OR RECENT ANTIBIOTIC USE
- ANTIBIOTIC RESISTANCE DETECTION
- PHARM D GUIDANCE BASED ON THE RESULTS OF MOLECULAR PATHOLOGY REPORT AND DETECTION OF ANTIBIOTIC RESISTANCE MECHANISMS